InvestorsHub Logo
Followers 10
Posts 478
Boards Moderated 0
Alias Born 02/10/2006

Re: MSC290 post# 14

Saturday, 08/04/2007 3:15:05 PM

Saturday, August 04, 2007 3:15:05 PM

Post# of 106
Thanks for the post.

I'm interested in Bruker's potential markets in follow on biologics. The biogeneric business is on the cusp of rapid growth and BRKR appears to be well situated as a toolmaker for biogeneric pharma. Here is an article I found interesting. Any comments?


FL

http://www.labtechnologist.com/news/ng.asp?n=77189-sandoz-momenta-pharmaceuticals-biogeneric-biosimi...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BRKR News